Table 1 –
Patient, tumor, and study characteristics
| Author (year) [reference no.] | Patient characteristics | Tumor characteristics | Study design | Reference standard | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period | Institution | No. | Age (yr), median (range) | No. | Pathological T stage | Histological subtype (no.) | Prospective | Multicenter | Consecutive enrollment | Method | MRI reference standard interval | ||
| Range | ≥T2 (%) | ||||||||||||
| Del Giudice et al (2020) [15] | Sep 2017–May 2019 | Sapienza University of Rome | 231 | 65.5 (47–79) | 103 | Ta-T4 | 27 | All urothelial | Yes | No | Yes | TUR a, RC | <6 wk |
| Kim (2020) [16] | Jan 2015–Mar 2019 | Kyungpook National University Hospital | 297 | 65.5 b (58–75) | 339 | Tis-T4 | 34 | Urothelial (320), urothelial with adenocarcinoma differentiation (14), undifferentiated (5) | No | No | Yes | TUR a, PC, RC | NR |
| Makboul et al (2019) [17] | NR | Assiut University Hospital | 50 | 57.2 b (NR) | 50 | T1-T4 | 36 | NR | Yes | No | Yes | TUR a | NR |
| Sakamoto et al (2019) [18] | 2013–2018 | Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital | 178 | NR | 178 | NR | 26 | NR | No | No | Yes | TUR | NR |
| Ueno et al (2019) [19] | 2010–2018 | Kobe University Graduate School of Medicine | 74 | NR | 74 | Tis-≥T2 | 50 | Urothelial (71), small cell (1), squamous cell (2) | No | No | Yes | TUR a | NR |
| Wang et al (2019) [20] | Nov 2011–Aug 2018 | First Affiliated Hospital of Sun Yat-Sen University | 340 | 64 (27–87) | 340 | Ta-T4 | 25 | All urothelial | No | No | Yes | TUR, PC, RC | <2 wk |
MIBC = muscle-invasive bladder cancer; MRI = magnetic resonance imaging; NR = not reported; PC = partial cystectomy; RC = radical cystectomy; TUR = transurethral resection
a
Confirmatory repeat TUR when clinically indicated (eg, high-grade non-MIBC, no muscle tissue in TUR specimen).
b
Mean.